Claudia Sangalli
A5066261714- Sarcoma Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Vascular Tumors and Angiosarcomas
- Cardiac tumors and thrombi
- Breast Lesions and Carcinomas
- Breast Implant and Reconstruction
- Bone Tumor Diagnosis and Treatments
- Lung Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Radiomics and Machine Learning in Medical Imaging
- Cancer Treatment and Pharmacology
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Neuroblastoma Research and Treatments
- Colorectal and Anal Carcinomas
- Oral and Maxillofacial Pathology
- Advances in Oncology and Radiotherapy
- Head and Neck Cancer Studies
- Soft tissue tumor case studies
- Cancer Risks and Factors
- HER2/EGFR in Cancer Research
- Lung Cancer Treatments and Mutations
- Medical Imaging Techniques and Applications
- Reconstructive Surgery and Microvascular Techniques
- BRCA gene mutations in cancer
Fondazione IRCCS Istituto Nazionale dei Tumori
2016-2025
European Institute of Oncology
2016-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2020-2024
Data Management (Italy)
2014-2024
Media Working Group
2024
Ripamonti
2007-2020
University of Milan
2008-2018
German Breast group
2017
Istituto Ortopedico Rizzoli
2015
Breast Center
2009
The aim of the present study was to compare effect radiotherapy (RT) on abdominal recurrence-free survival (ARFS) in patients with primary retroperitoneal sarcoma treated EORTC-STBSG-62092 (STRASS) phase 3 randomized controlled trial (STRASS cohort) and off-trial (STREXIT pool STRASS STREXIT data test hypothesis that RT improves ARFS liposarcoma.The did not show any difference between preoperative radiotherapy+surgery (RT+S) versus surgery alone (S).All consecutive adult enrolled underwent...
11001 Background: The predominant pattern of failure retroperitoneal sarcoma (RPS), frequently associated with subsequent death, is locoregional recurrence. Unlike in limbs, the efficacy radiotherapy (RT) combined surgery not established. Methods: STRASS a randomized, multicentre, international trial. Eligible patients had histologically-proven localized primary RPS, operable and suitable for radiotherapy. Patients were randomized 1:1 to preoperative RT (3D-CRT or IMRT) 50.4 Gy followed by...
REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk late toxicity following radiotherapy. The purpose this article is provide summary descriptive data.
Objective: The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients. Summary Background Data: As the use nipple sparing continues rise, improved understanding surgical, oncologic, and quality life is imperative for appropriate patient selection as well better understand indications, limits, advantages, dangers. Methods: In a phase III, label, single-center, randomized controlled trial involving 80 women (69) or BRCA mutation...
Preclinical data about the synergistic activity of radiotherapy (RT) and trabectedin have been reported. The combination RT in treating myxoid liposarcomas appears worth exploring.